LKB1IP promotes pathological cardiac hypertrophy by targeting PTEN/Akt signalling pathway
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Cellular and Molecular Medicine"
DOI: 10.1111/jcmm.16199
Abstract: Pathological cardiac hypertrophy represents a leading cause of morbidity and mortality worldwide. Liver kinase B1 interacting protein 1 (LKB1IP) was identified as the binding protein of tumour suppressor LKB1. However, the role of LKB1IP in… read more here.
Keywords: cardiac hypertrophy; lkb1ip; hypertrophy; pathological cardiac ... See more keywords